Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Preparing for a Polio-Free World

Supporting the development of new tests to assess mucosal immunity against polio

To date, smallpox is the only human infectious disease which has been eradicated, demonstrating the difficulty of eliminating a microbe from the environment. Currently, wild polio is only circulating in parts of Afghanistan, Pakistan, and Nigeria, bringing global eradication within sight. Harish Verma, along with colleagues at the World Health Organization (WHO) Polio Research unit, and collaborators across the globe are hard at work developing and deploying the most effective tools to stop the virus’s transmission…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

RT @MilliporeSigma: Join us at #AACR17 to empower your cancer research. Put an oncology heavyweight in your corner. #empowerAACR https://t.
h J R
We're at booth 19 at the #SCACM Spring Meeting! Stop by this afternoon for a demo of the ARIES M1 System.
h J R
A doctor found a possible treatment for deadly #sepsis. by @NPR
h J R

Latest News

March 1
Luminex Corporation To Present At The Barclays Global Healthcare Conference

February 21
Luminex Corporation Announces Initiation of Cash Dividend

February 6
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

January 9
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

January 4
Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay

December 5
Luminex wins R&D 100 Award for ARIES Systems


NCASM Spring Meeting
March 3-4
San Francisco, CA

FAH Public Policy Conference & Business Expo
March 5-7
Washington, DC

SCACM Spring Meeting
March 23-25
Indianapolis, IN

CLMA KnowledgeLab 2017
March 27-28
Nashville, TN

March 30
Indianapolis, IN